Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:932-939

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kähler, C. M.
Right arrow Articles by Wiedermann, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kähler, C. M.
Right arrow Articles by Wiedermann, C. J.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:932-939.)
© 1997 American Heart Association, Inc.


Articles

Inhibition of Proliferation and Stimulation of Migration of Endothelial Cells by Secretoneurin In Vitro

Christian M. Kähler; Rudolf Kirchmair; Gerhard Kaufmann; Stefan T. Kähler; Norbert Reinisch; Reiner Fischer-Colbrie; Ruth Hogue-Angeletti; Hans Winkler; ; Christian J. Wiedermann

From the Departments of Internal Medicine (C.M.K., R.K., G.K., N.R., C.J.W.) and Pharmacology, (R.F.-C., H.W.), Faculty of Medicine, and the Department of Pharmacology and Toxicology, Faculty of Pharmacology (S.T.K.), University of Innsbruck, Austria; and the Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, New York, NY (R.H.-A.).

Abstract Vascular cell responses in inflammation are affected by several neuropeptides of perivascular nerve fibers. Secretoneurin is a 33–amino acid peptide that is coreleased from these nerve endings with other proinflammatory neuropeptides, eg, substance P and calcitonin gene–related peptide. Furthermore, secretoneurin has been shown to be chemotactic for human skin fibroblasts and human blood monocytes in vitro and in vivo. An action on cellular components of the vascular wall is not yet reported. We therefore investigated in vitro effects of this novel sensory neuropeptide on endothelial cells. Secretoneurin exerted a potent and reversible inhibitory effect both on endothelial cell growth under low serum conditions (1% fetal calf serum) and endothelial cell growth factor–activated endothelial cell proliferation. We show in the present study that secretoneurin exerts this effect on aortic (rat) and pulmonary artery (bovine) endothelial cells, as well as venous (human umbilical vein) endothelium. Endothelial cell chemotaxis was tested by means of three different migration assays employing nitrocellulose and polycarbonate micropore filters. Secretoneurin consistently exhibited potent chemoattractant activity. The effective concentrations for the observed effects were in the picomolar range. The combination of chemotactic and antiproliferative effects on endothelial cells suggests that secretoneurin may act as a regulatory factor of vascular cell functions.


Key Words: secretoneurin • endothelial cells • proliferation • migration • neuropeptide




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
D. Roosterman, T. Goerge, S. W. Schneider, N. W. Bunnett, and M. Steinhoff
Neuronal control of skin function: the skin as a neuroimmunoendocrine organ.
Physiol Rev, October 1, 2006; 86(4): 1309 - 1379.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Troger, A. Doblinger, J. Leierer, A. Laslop, E. Schmid, B. Teuchner, M. Opatril, W. Philipp, L. Klimaschewski, K. Pfaller, et al.
Secretoneurin in the Peripheral Ocular Innervation
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 647 - 654.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Kirchmair, R. Gander, M. Egger, A. Hanley, M. Silver, A. Ritsch, T. Murayama, N. Kaneider, W. Sturm, M. Kearny, et al.
The Neuropeptide Secretoneurin Acts as a Direct Angiogenic Cytokine In Vitro and In Vivo
Circulation, February 17, 2004; 109(6): 777 - 783.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. C. Kaneider, P. Egger, S. Dunzendorfer, P. Noris, C. L. Balduini, D. Gritti, G. Ricevuti, and C. J. Wiedermann
Reversal of Thrombin-Induced Deactivation of CD39/ATPDase in Endothelial Cells by HMG-CoA Reductase Inhibition: Effects on Rho-GTPase and Adenosine Nucleotide Metabolism
Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 894 - 900.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. S. C. Weber, P. J. Nelson, H.-J. Grone, and C. Weber
Expression of CCR2 by Endothelial Cells : Implications for MCP-1 Mediated Wound Injury Repair and In Vivo Inflammatory Activation of Endothelium
Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2085 - 2093.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Anouar, C. Desmoucelles, L. Yon, J. Leprince, L. Breault, N. Gallo-Payet, and H. Vaudry
Identification of a Novel Secretogranin II-Derived Peptide (SgII187-252) in Adult and Fetal Human Adrenal Glands Using Antibodies Raised against the Human Recombinant Peptide
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2944 - 2951.
[Abstract] [Full Text]